C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) A61K 48/00 (2006.01) C07H 21/00 (2006.01) C07H 21/04 (2006.01) C12N 15/11 (2006.01) C12Q 1/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2322773
Compounds, compositions and methods are provided for inhibiting the expression of human mdm2. The compositions include antisense compounds targeted to nucleic acids encoding mdm2. Methods of using these oligonucleotides for inhibition of mdm2 expression and for treatment of diseases such as cancers associated with overexpression of mdm2 are provided.
L'invention concerne des composés, des compositions et des procédés qui inhibent l'expression du gène mdm2 humain. Les compositions comprennent notamment des composés antisens qui ciblent des acides nucléiques codant pour mdm2. L'invention concerne des procédés d'utilisation de ces oligonucléotides pour inhiber l'expression de mdm2 et pour traiter des maladies, tels des cancers, associées à une surexpression de mdm2.
Cowsert Lex M.
Graham Mark J.
Miraglia Loren J.
Monia Brett P.
Nero Pamela
Borden Ladner Gervais Llp
Isis Pharmaceuticals Inc.
LandOfFree
Antisense modulation of human mdm2 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of human mdm2 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of human mdm2 expression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2067838